Today: 22 July 2026
Kratos Defense & Security Solutions Stock Drops 9% as Wall Street Rout Pulls Shares Back Toward $84 Deal Price
22 March 2026
1 min read

Kratos Defense & Security Solutions Stock Drops 9% as Wall Street Rout Pulls Shares Back Toward $84 Deal Price

NEW YORK, March 22, 2026, 12:17 PM EDT

Kratos Defense & Security Solutions wrapped up Friday at $84.62, down 8.79%. The stock started out at $91.45 but tumbled all the way to $83.10 during the session. That move shoved shares back into the mid-$80s, marking one more tough day for Kratos.

Kratos is back near the $84 mark it aimed for in February—right around the time it raised cash by selling shares to support capital plans, roll out new products, and pursue deals. But judging by the decline, investors still seem hesitant about the company’s growth narrative following that fresh stock supply.

Kratos wasn’t the only casualty Friday—selling hit broad swaths of the market. The S&P 500 shed 1.51%. The Nasdaq fell harder, down 2.01%. Fresh U.S.-Israeli strikes in Iran rattled traders already worried about inflation and rates. AeroVironment dropped 6.4%. Red Cat plunged 12.5%. “This conflict may go on longer than initially expected,” Jake Dollarhide at Longbow Asset Management told Reuters. Reuters

No new contract news or guidance updates from Kratos with this jump. The last press release in the company’s newsroom dates back to March 13—a Valkyrie program update with Airbus. Over on the investor site, the latest filing is still the preliminary proxy from March 20.

That’s one reason the shares still signal where defense budgets and demand for unmanned systems are headed. Last September, Reuters pointed out that smaller defense players—Kratos and AeroVironment among them—ranked among the sector’s strongest gainers, as Pentagon spending kept flowing into drones and anti-drone gear. Seaport Research’s Richard Safran didn’t mince words: investors should “follow the money.” Reuters

Kratos is still right in the thick of things. In February, Reuters reported the company and Taiwan ran trials on a jet-powered attack drone, with a push to field “large numbers” of cost-effective units. Fast forward to Friday: the Pentagon rolled out plans for a U.S.-led group to ramp up drone work in Asia and kick off missile motor manufacturing with Japan. Reuters

Kratos surprised Wall Street last earnings season—2025 revenue jumped 18.5% to $1.347 billion, backlog climbed to a record $1.573 billion, and management pointed to a $13.7 billion contract pipeline. CEO Eric DeMarco described the company’s opportunity set as the strongest on record. Still, there’s a wrinkle: Kratos warned the first quarter of 2026 will likely be the year’s slowest, and said guidance won’t reflect major Valkyrie production until those customer delivery dates are locked in.

The underwriters took down their full allocation in the equity offering, according to a March 2 SEC filing, bringing the total to 16.4 million shares at $84 apiece. Kratos wrapped up Friday trading at $84.62, barely above the deal price.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Biotech Shares Rally as Investor Sentiment Improves
    July 22, 2026, 4:34 PM EDT. State Street SPDR S & P Biotech ETF (XBI) and iShares Biotechnology ETF (IBB) have both posted gains of nearly 80% and more than 40% over 12 months, surpassing the S & P 500's performance. Investors point to fast-expiring patents, increased likelihood of M&A activity, and a rebounding clinical trial landscape as major factors. Franklin Biotechnology Discovery Fund's FBDIX advanced 18% in 2026, as investor optimism grows around new drug launches like Revolution Medicines' potential treatment for pancreatic cancer.
Palantir Stock Price Today: PLTR Slips Even After New Navy ShipOS Push
Previous Story

Palantir Stock Price Today: PLTR Slips Even After New Navy ShipOS Push

Bitcoin Price Today: BTC Drops Below $69,000 as Iran Relief Rally Fades, Coinbase and Strategy Slide
Next Story

Bitcoin Price Today: BTC Drops Below $69,000 as Iran Relief Rally Fades, Coinbase and Strategy Slide

Go toTop